Results 1 to 10 of about 2,966 (119)

Multimodal therapy and precision-imaging extends the limits of treatment for a patient with initially unresectable synchronous colorectal liver metastases. [PDF]

Ann R Coll Surg Engl
Sidhom M, Morrison-Jones V, Harinarayanan S, Nolan L, Welsh F.   +4 more
europepmc   +1 more source

Colorectal Cancer with Ovarian Metastasis After Panitumumab and FOLFOX4: A Case Report. [PDF]

Am J Case Rep
Koper A, Wileński S, Koper K.
europepmc   +1 more source

5-Fluorouracil-Related Lactic Acidosis in a Patient with Colon Cancer. [PDF]

Intern Med
Osawa Y, Kazaoka M, Akita T, Nemoto D, Ohtake T.   +4 more
europepmc   +1 more source

A next-generation multimetal complex induces immunogenic cell death with distinct transcriptomic signatures.

Chem Commun (Camb)
Babu T, Levine MS, Zeng B, Sessler JL.
europepmc   +1 more source

Golden immunity: gold complexes as emerging triggers of immunogenic cell death. [PDF]

Chem Sci
Redrado M, Gimeno MC.
europepmc   +1 more source

Recurrent Cytokine Release Syndrome in Metastatic Gastric Cancer on Nivolumab-FOLFOX: A Case Report and Mechanistic Review. [PDF]

J Gastrointest Cancer
Islam J, Rashid Z, Munster AB, Hughes P, Badzek S, Huda I.   +5 more
europepmc   +1 more source

Maintaining oxaliplatin therapy after hypersensitivity reactions: real-world experience with a desensitisation protocol. [PDF]

Clin Exp Med
Christodoulis E, Vlachostergios PJ, Connell J, Williams J, Hasan J, Mansoor W, Mullamitha S, Hubner RA, Braun M, Saunders MP, Marti Marti F, Angelakas A, Waddell T, Alam N, Kamposioras K.   +14 more
europepmc   +1 more source

Real-world evidence on second line chemotherapy in advanced biliary tract carcinoma refractory to gemcitabine and oxaliplatin (GemOx). [PDF]

BMC Cancer
Lagenfelt H, Blomstrand H, Gränsmark E, Elander NO.   +3 more
europepmc   +1 more source

Temporal association of diffuse large B-cell lymphoma with PD-1 inhibitor therapy in a patient with gastric adenocarcinoma: a case report. [PDF]

Front Immunol
Jiang Y, Wu K, Hu J, Yu M, Xu Y, Xu Z, Cao R, Zhang Y, Gao Y, Liu S, Ding Y.   +10 more
europepmc   +1 more source

Safety and efficacy of nab-paclitaxel combined with nedaplatin and bevacizumab in patients with platinum-resistant epithelial ovarian cancer: a retrospective cohort study. [PDF]

J Cancer Res Clin Oncol
Li S, Xian B, Cui L, Wu L, Fang C, Yang F, Li J.   +6 more
europepmc   +1 more source